| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.3390/IJMS20010075 |
| P953 | full work available at URL | https://www.mdpi.com/1422-0067/20/1/75 |
| P932 | PMC publication ID | 6337524 |
| P698 | PubMed publication ID | 30585189 |
| P50 | author | Hai-Ying Mo | Q60985925 |
| Heng Wee Tan | Q60985934 | ||
| Yan-Ming Xu | Q87738543 | ||
| Andy T Y Lau | Q87738545 | ||
| P2860 | cites work | Methylseleninic acid enhances paclitaxel efficacy for the treatment of triple-negative breast cancer | Q21134780 |
| Se-methylselenocysteine inhibits phosphatidylinositol 3-kinase activity of mouse mammary epithelial tumor cells in vitro | Q24813505 | ||
| From selenium to selenoproteins: synthesis, identity, and their role in human health | Q27863358 | ||
| Free radicals, metals and antioxidants in oxidative stress-induced cancer | Q29547711 | ||
| Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT) | Q29619860 | ||
| Gamma-radiation synthesis of silk fibroin coated CdSe quantum dots and their biocompatibility and photostability in living cells. | Q30883228 | ||
| Methyl-selenium compounds inhibit prostate carcinogenesis in the transgenic adenocarcinoma of mouse prostate model with survival benefit | Q33657004 | ||
| Health risk assessment of environmental selenium: Emerging evidence and challenges (Review) | Q33671643 | ||
| Strategy to enhance the therapeutic effect of doxorubicin in human hepatocellular carcinoma by selenocystine, a synergistic agent that regulates the ROS-mediated signaling | Q33757127 | ||
| Biogenic selenium nanoparticles induce ROS-mediated necroptosis in PC-3 cancer cells through TNF activation | Q33776949 | ||
| Comparison of short-term toxicity between Nano-Se and selenite in mice | Q33984059 | ||
| Se-methylselenocysteine sensitizes hypoxic tumor cells to irinotecan by targeting hypoxia-inducible factor 1alpha | Q34047866 | ||
| Decreased selenium-binding protein 1 in esophageal adenocarcinoma results from posttranscriptional and epigenetic regulation and affects chemosensitivity | Q34193882 | ||
| Adverse health effects of selenium in humans | Q34663990 | ||
| Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597. | Q34977797 | ||
| Epigenetic regulation of inflammatory gene expression in macrophages by selenium. | Q34995953 | ||
| Impact of reactive oxygen species on antioxidant capacity of male reproductive system | Q42486429 | ||
| Modulation of MHC class I surface expression in B16F10 melanoma cells by methylseleninic acid. | Q42511974 | ||
| Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. | Q42528232 | ||
| Reduction of organic and inorganic selenium compounds by the edible medicinal basidiomycete Lentinula edodes and the accumulation of elemental selenium nanoparticles in its mycelium. | Q44767709 | ||
| Effects of selenium compounds on proliferation and epigenetic marks of breast cancer cells | Q45036855 | ||
| Thioredoxin reductase regulates angiogenesis by increasing endothelial cell-derived vascular endothelial growth factor | Q45204941 | ||
| Cancer chemoprevention: selenium as a prooxidant, not an antioxidant | Q45844552 | ||
| Efficient induction of apoptosis in cancer cells by paclitaxel-loaded selenium nanoparticles | Q46281941 | ||
| GE11 peptide conjugated selenium nanoparticles for EGFR targeted oridonin delivery to achieve enhanced anticancer efficacy by inhibiting EGFR-mediated PI3K/AKT and Ras/Raf/MEK/ERK pathways. | Q46289176 | ||
| Mitochondrial Dysfunction and Redox Imbalance as a Diagnostic Marker of "Free Radical Diseases". | Q46293531 | ||
| Combination of methylselenocysteine with tamoxifen inhibits MCF-7 breast cancer xenografts in nude mice through elevated apoptosis and reduced angiogenesis | Q46316695 | ||
| Selenopheno quinolinones and coumarins promote cancer cell apoptosis by ROS depletion and caspase-7 activation. | Q46321220 | ||
| Functionalized Selenium Nanosystem as Radiation Sensitizer of 125I Seeds for Precise Cancer Therapy. | Q46334498 | ||
| The effects of combined selenium nanoparticles and radiation therapy on breast cancer cells in vitro | Q46339387 | ||
| Selenium nanoparticles induce suppressed function of tumor associated macrophages and inhibit Dalton's lymphoma proliferation | Q47100968 | ||
| Ochrobactrum sp. MPV1 from a dump of roasted pyrites can be exploited as bacterial catalyst for the biogenesis of selenium and tellurium nanoparticles | Q47157213 | ||
| Speeding up bioproduction of selenium nanoparticles by using Vibrio natriegens as microbial factory. | Q47162327 | ||
| pH-responsive selenium nanoparticles stabilized by folate-chitosan delivering doxorubicin for overcoming drug-resistant cancer cells | Q47237655 | ||
| Recent insights into human bronchial proteomics - how are we progressing and what is next? | Q47271963 | ||
| Elemental selenium at nano size (Nano-Se) as a potential chemopreventive agent with reduced risk of selenium toxicity: comparison with se-methylselenocysteine in mice | Q47272648 | ||
| An increase in selenium intake improves immune function and poliovirus handling in adults with marginal selenium status | Q47303472 | ||
| Self-assembled selenium nanoparticles and their application in the rapid diagnostic detection of small cell lung cancer biomarkers | Q47312419 | ||
| Aptamer-modified selenium nanoparticles for dark-field microscopy imaging of nucleolin | Q47325040 | ||
| Application of Sodium Selenite in the Prevention and Treatment of Cancers. | Q47422547 | ||
| Update on Nanotechnology-based Drug Delivery Systems in Cancer Treatment | Q47566683 | ||
| Development, physicochemical characterization and cytotoxicity of selenium nanoparticles stabilized by beta-lactoglobulin | Q47582573 | ||
| Selenium-containing indolyl compounds: Kinetics of reaction with inflammation-associated oxidants and protective effect against oxidation of extracellular matrix proteins | Q47620591 | ||
| Selenocompounds in Cancer Therapy: An Overview. | Q47622832 | ||
| Gd3+-Doped MoSe2 nanosheets used as a theranostic agent for bimodal imaging and highly efficient photothermal cancer therapy | Q47732160 | ||
| Selenium and Epigenetics in Cancer: Focus on DNA Methylation | Q47751861 | ||
| Sodium selenate activated Wnt/β-catenin signaling and repressed amyloid-β formation in a triple transgenic mouse model of Alzheimer's disease. | Q47970560 | ||
| Synergism between thioredoxin reductase inhibitor ethaselen and sodium selenite in inhibiting proliferation and inducing death of human non-small cell lung cancer cells | Q48011659 | ||
| Se/Ru-Decorated Porous Metal-Organic Framework Nanoparticles for The Delivery of Pooled siRNAs to Reversing Multidrug Resistance in Taxol-Resistant Breast Cancer Cells | Q48047480 | ||
| Inhibition of Thioredoxin Reductase by Targeted Selenopolymeric Nanocarriers Synergizes the Therapeutic Efficacy of Doxorubicin in MCF7 Human Breast Cancer Cells. | Q48296762 | ||
| Novel organic/inorganic hybrid flower-like structure of selenium nanoparticles stabilized by pullulan derivatives | Q48530229 | ||
| Targeted co-delivery of epirubicin and NAS-24 aptamer to cancer cells using selenium nanoparticles for enhancing tumor response in vitro and in vivo | Q48565442 | ||
| Anticancer properties of sodium selenite in human glioblastoma cell cluster spheroids | Q48645248 | ||
| Dual-Targeted Selenium Nanoparticles for Synergistic Photothermal Therapy and Chemotherapy of Tumor | Q49354302 | ||
| Selenite and methylseleninic acid epigenetically affects distinct gene sets in myeloid leukemia: A genome wide epigenetic analysis | Q50040158 | ||
| Early-Life Selenium Status and Cognitive Function at 5 and 10 Years of Age in Bangladeshi Children | Q50106884 | ||
| Sodium Selenite as an Anticancer Agent | Q50238013 | ||
| Biosynthesis of Se nanoparticles and its effect on UV-induced DNA damage. | Q50487292 | ||
| Curcumin loading potentiates the chemotherapeutic efficacy of selenium nanoparticles in HCT116 cells and Ehrlich's ascites carcinoma bearing mice. | Q50651551 | ||
| Synergistic Effects of SAM and Selenium Compounds on Proliferation, Migration and Adhesion of HeLa Cells. | Q50873073 | ||
| On the hypoxic tumor targeting ability of two chitosan micelles loaded with oil-soluble CdSe quantum dots. | Q51812542 | ||
| Nano-selenium and its nanomedicine applications: a critical review. | Q52564739 | ||
| Cancer incidence following long-term consumption of drinking water with high inorganic selenium content. | Q52576729 | ||
| Selenium and Iron Oxide Nanocomposites for Magnetically-Targeted Anti-Cancer Applications. | Q52583570 | ||
| siRNA-loaded selenium nanoparticle modified with hyaluronic acid for enhanced hepatocellular carcinoma therapy. | Q52626678 | ||
| Strategies for the development of selenium-based anticancer drugs. | Q52651630 | ||
| Selenides and Diselenides: A Review of Their Anticancer and Chemopreventive Activity. | Q52657769 | ||
| Construction of a Cordyceps sinensis exopolysaccharide-conjugated selenium nanoparticles and enhancement of their antioxidant activities. | Q52894029 | ||
| Se-Allylselenocysteine induces autophagy by modulating the AMPK/mTOR signaling pathway and epigenetic regulation of PCDH17 in human colorectal adenocarcinoma cells. | Q53213339 | ||
| D-501036, a novel selenophene-based triheterocycle derivative, exhibits potent in vitro and in vivo antitumoral activity which involves DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation. | Q53576239 | ||
| Selenium Nanoparticles Induce the Chemo-Sensitivity of Fluorouracil Nanoparticles in Breast and Colon Cancer Cells. | Q53683390 | ||
| Tumor angiogenesis and anti-angiogenic gene therapy for cancer. | Q55385227 | ||
| A comprehensive review on green nanomaterials using biological systems: Recent perception and their future applications | Q57136021 | ||
| Higher Plasma Selenium Concentrations Are Associated with Increased Odds of Prevalent Type 2 Diabetes | Q57172823 | ||
| The Interaction of Selenium with Chemotherapy and Radiation on Normal and Malignant Human Mononuclear Blood Cells | Q57463129 | ||
| The Epidemiology of Selenium and Human Cancer | Q58800438 | ||
| Novel Methylselenoesters Induce Programed Cell Death via Entosis in Pancreatic Cancer Cells | Q59133924 | ||
| Selenium-induced cell migration and proliferation: relevance to angiogenesis and microangiopathy | Q68969374 | ||
| Studies on analogues of L-cysteine and L-cystine. II. The effect of selenium cystine on Murphy lymphosarcoma tumor cells in the rat | Q73876012 | ||
| Studies on analogues of L-cysteine and L-cystine. III. The effect of selenium cystine on leukemia | Q73876015 | ||
| A novel organoselenium compound induces cell cycle arrest and apoptosis in prostate cancer cell lines | Q73916834 | ||
| Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial | Q74420302 | ||
| The activity of 6-selenopurine and related compounds against some experimental mouse tumors | Q77062401 | ||
| Selenium and mortality in the elderly: results from the EVA study | Q81117993 | ||
| Selenium toxicity: a case of selenosis caused by a nutritional supplement | Q81469977 | ||
| Sodium selenosulfate at an innocuous dose markedly prevents cisplatin-induced gastrointestinal toxicity | Q82977119 | ||
| Synthesis and antioxidant capacity of 5-selenopyranose derivatives | Q84617236 | ||
| Electrochemical quantum dots-based magneto-immunoassay for detection of HE4 protein on metal film-modified screen-printed carbon electrodes | Q87946662 | ||
| Sodium selenite attenuates lung adenocarcinoma progression by repressing SOX2-mediated stemness | Q88076021 | ||
| Characterization of Folic Acid Surface-Coated Selenium Nanoparticles and Corresponding In Vitro and In Vivo Effects Against Breast Cancer | Q88486703 | ||
| Targetable Mesoporous Silica Nanoprobes for Mapping the Subcellular Distribution of H2Se in Cancer Cells | Q88512206 | ||
| Organic selenium compounds as potential chemotherapeutic agents for improved cancer treatment | Q88628749 | ||
| Synthesis, characterization and antitumor properties of selenium nanoparticles coupling with ferulic acid | Q88936495 | ||
| Selenium nanoparticles: A potent chemotherapeutic agent and an elucidation of its mechanism | Q89219165 | ||
| Redox-responsive mesoporous selenium delivery of doxorubicin targets MCF-7 cells and synergistically enhances its anti-tumor activity | Q89428061 | ||
| Construction, stability, and enhanced antioxidant activity of pectin-decorated selenium nanoparticles | Q89476517 | ||
| Selenium nanoparticles are more efficient than sodium selenite in producing reactive oxygen species and hyper-accumulation of selenium nanoparticles in cancer cells generates potent therapeutic effects | Q90590710 | ||
| Autophagy is an important action mode for functionalized selenium nanoparticles to exhibit anti-colorectal cancer activity | Q90850989 | ||
| Delivery of a TNF-α-derived peptide by nanoparticles enhances its antitumor activity by inducing cell-cycle arrest and caspase-dependent apoptosis | Q91222505 | ||
| Effects of exercise training and supplementation with selenium nanoparticle on T-helper 1 and 2 and cytokine levels in tumor tissue of mice bearing the 4 T1 mammary carcinoma | Q91251476 | ||
| Light-activatable dual-source ROS-responsive prodrug nanoplatform for synergistic chemo-photodynamic therapy | Q91745998 | ||
| Methylselenocysteine: a promising antiangiogenic agent for overcoming drug delivery barriers in solid malignancies for therapeutic synergy with anticancer drugs | Q35034404 | ||
| Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy | Q35039281 | ||
| Biomolecule-mediated synthesis of selenium nanoparticles using dried Vitis vinifera (raisin) extract. | Q35105299 | ||
| Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917. | Q35528860 | ||
| Redox-active selenium compounds--from toxicity and cell death to cancer treatment | Q35658137 | ||
| Selenate specifically sensitizes drug-resistant cancer cells by increasing apoptosis via G2 phase cell cycle arrest without P-GP inhibition | Q35680717 | ||
| Pharmacokinetics and Toxicity of Sodium Selenite in the Treatment of Patients with Carcinoma in a Phase I Clinical Trial: The SECAR Study. | Q35809064 | ||
| Superior in vivo inhibitory efficacy of methylseleninic acid against human prostate cancer over selenomethionine or selenite. | Q35853576 | ||
| Randomized phase II trial of selenomethionine as a modulator of efficacy and toxicity of chemoradiation in squamous cell carcinoma of the head and neck | Q36143844 | ||
| Inhibition of Candida albicans biofilm by pure selenium nanoparticles synthesized by pulsed laser ablation in liquids | Q36177794 | ||
| Epigenetic effects of selenium and their implications for health | Q36216208 | ||
| Visible light-induced crosslinking and physiological stabilization of diselenide-rich nanoparticles for redox-responsive drug release and combination chemotherapy | Q36244438 | ||
| Selenium in cancer prevention: a review of the evidence and mechanism of action | Q36325137 | ||
| Apoptosis and non-apoptotic deaths in cancer development and treatment response | Q37250355 | ||
| Extracellular thiol-assisted selenium uptake dependent on the x(c)- cystine transporter explains the cancer-specific cytotoxicity of selenite. | Q37256851 | ||
| Selenium and anticarcinogenesis: underlying mechanisms | Q37283275 | ||
| Selenite reactivates silenced genes by modifying DNA methylation and histones in prostate cancer cells | Q37294669 | ||
| Selenium level and cognitive function in rural elderly Chinese | Q37385106 | ||
| Selenoproteins that function in cancer prevention and promotion | Q37392209 | ||
| Antioxidant capacities of the selenium nanoparticles stabilized by chitosan | Q37566587 | ||
| Using CdTe/ZnSe core/shell quantum dots to detect DNA and damage to DNA. | Q37652838 | ||
| Se-methylselenocysteine offers selective protection against toxicity and potentiates the antitumour activity of anticancer drugs in preclinical animal models | Q37681776 | ||
| Selenium: a double-edged sword for defense and offence in cancer | Q37792840 | ||
| Selenium in reproductive health | Q37941249 | ||
| Selenium compounds, apoptosis and other types of cell death: an overview for cancer therapy | Q38040788 | ||
| Selenium-containing amino acids as direct and indirect antioxidants | Q38054005 | ||
| Which form is that? The importance of selenium speciation and metabolism in the prevention and treatment of disease | Q38137010 | ||
| Selenium compounds as therapeutic agents in cancer. | Q38280346 | ||
| Aerobic biogenesis of selenium nanoparticles by Enterobacter cloacae Z0206 as a consequence of fumarate reductase mediated selenite reduction | Q38400534 | ||
| Surface functionalized selenium nanoparticles for biomedical applications | Q38493405 | ||
| Proteins in microbial synthesis of selenium nanoparticles | Q38664465 | ||
| Biogenic selenium nanoparticles: current status and future prospects | Q38708519 | ||
| Interleukin-13 conjugated quantum dots for identification of glioma initiating cells and their extracellular vesicles. | Q38742237 | ||
| Selenium potentiates the anticancer effect of cisplatin against oxidative stress and calcium ion signaling-induced intracellular toxicity in MCF-7 breast cancer cells: involvement of the TRPV1 channel | Q38780004 | ||
| Reactive oxygen species (ROS) and cancer: Role of antioxidative nutraceuticals | Q38795955 | ||
| Cytotoxic activity of selenosulfate versus selenite in tumor cells depends on cell line and presence of amino acids | Q38802405 | ||
| Se-Methyl-L-selenocysteine Induces Apoptosis via Endoplasmic Reticulum Stress and the Death Receptor Pathway in Human Colon Adenocarcinoma COLO 205 Cells | Q38878823 | ||
| Selenium nanoparticles as a nutritional supplement. | Q38880883 | ||
| Selenium and redox signaling | Q38919874 | ||
| Cytotoxicity and therapeutic effect of irinotecan combined with selenium nanoparticles. | Q38971381 | ||
| Upregulation of KLF4 by methylseleninic acid in human esophageal squamous cell carcinoma cells: Modification of histone H3 acetylation through HAT/HDAC interplay | Q38999422 | ||
| Contribution of mammalian selenocysteine-containing proteins to carcinogenesis. | Q39026250 | ||
| Cisplatin-resistant prostate cancer model: Differences in antioxidant system, apoptosis and cell cycle. | Q39040443 | ||
| Antioxidant and cytotoxic effect of biologically synthesized selenium nanoparticles in comparison to selenium dioxide. | Q39090510 | ||
| Epigenetic approach for angiostatic therapy: promising combinations for cancer treatment | Q39220891 | ||
| Selenium nanoparticles: potential in cancer gene and drug delivery. | Q39261156 | ||
| Methylseleninic acid is a novel suppressor of aromatase expression | Q39435444 | ||
| Selenite induces posttranscriptional blockade of HLA-E expression and sensitizes tumor cells to CD94/NKG2A-positive NK cells. | Q39479665 | ||
| The reversal of cisplatin-induced nephrotoxicity by selenium nanoparticles functionalized with 11-mercapto-1-undecanol by inhibition of ROS-mediated apoptosis | Q39485185 | ||
| Enhancement of non-homologous end joining DNA repair capacity confers cancer cells resistance to the novel selenophene compound, D-501036. | Q39522135 | ||
| Combined effect of sodium selenite and docetaxel on PC3 metastatic prostate cancer cell line | Q39546941 | ||
| In situ diselenide-crosslinked polymeric micelles for ROS-mediated anticancer drug delivery. | Q39636575 | ||
| Differential apoptotic response of human cancer cells to organoselenium compounds | Q39770351 | ||
| Antiproliferative effects of selenium compounds in colon cancer cells: comparison of different cytotoxicity assays. | Q39824650 | ||
| Treatment of human cancer cells with selenite or tellurite in combination with auranofin enhances cell death due to redox shift | Q39844330 | ||
| Selenium bioavailability: current knowledge and future research requirements | Q39895374 | ||
| Methylseleninic acid synergizes with tamoxifen to induce caspase-mediated apoptosis in breast cancer cells | Q39940011 | ||
| Modulation of redox status in human lung cell lines by organoselenocompounds: selenazolidines, selenomethionine, and methylseleninic acid | Q39944061 | ||
| Ebselen sensitizes glioblastoma cells to Tumor Necrosis Factor (TNFalpha)-induced apoptosis through two distinct pathways involving NF-kappaB downregulation and Fas-mediated formation of death inducing signaling complex. | Q39949761 | ||
| Differential sensitivity of various human tumour-derived cell types to apoptosis by organic derivatives of selenium | Q39972955 | ||
| Biomedical potential of actinobacterially synthesized selenium nanoparticles with special reference to anti-biofilm, anti-oxidant, wound healing, cytotoxic and anti-viral activities | Q40142050 | ||
| Mitochondria-mediated and p53-associated apoptosis induced in human cancer cells by a novel selenophene derivative, D-501036. | Q40200047 | ||
| Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA). | Q40287838 | ||
| Near-Infrared Fluorescent Ag2 Se-Cetuximab Nanoprobes for Targeted Imaging and Therapy of Cancer | Q40382220 | ||
| Possible role of glutathione in mitochondrial apoptosis of human oral squamous cell carcinoma caused by inorganic selenium compounds. | Q40398768 | ||
| Effect of selenite combined with chemotherapeutic agents on the proliferation of human carcinoma cell lines | Q40538928 | ||
| Selective modulation of the therapeutic efficacy of anticancer drugs by selenium containing compounds against human tumor xenografts | Q40568556 | ||
| Selenite-induced apoptosis in doxorubicin-resistant cells and effects on the thioredoxin system | Q40575222 | ||
| Low Population Selenium Status Is Associated With Increased Prevalence of Thyroid Disease | Q40609229 | ||
| Drug-resistant human lung cancer cells are more sensitive to selenium cytotoxicity. Effects on thioredoxin reductase and glutathione reductase | Q40729118 | ||
| Preparation and antioxidant properties of selenium nanoparticles-loaded chitosan microspheres | Q41034815 | ||
| Effects of organic and inorganic selenium compounds on rat mammary tumor cells | Q41272835 | ||
| Microbial transformations of selenite by methane-oxidizing bacteria. | Q41368205 | ||
| Fabrication and physicochemical characterization of porous composite microgranules with selenium oxyanions and risedronate sodium for potential applications in bone tumors. | Q41415611 | ||
| Keshan disease, selenium deficiency, and the selenoproteome | Q42217155 | ||
| Green synthesis of selenium nanoparticles using Acinetobacter sp. SW30: optimization, characterization and its anticancer activity in breast cancer cells | Q42218388 | ||
| Treatment with a selenium-platinum compound induced T-cell acute lymphoblastic leukemia/lymphoma cells apoptosis through the mitochondrial signaling pathway | Q42290632 | ||
| Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial | Q42456979 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | selenium | Q876 |
| inorganic compound | Q190065 | ||
| neoplasm | Q1216998 | ||
| P304 | page(s) | 75 | |
| P577 | publication date | 2018-12-25 | |
| 2019-01-01 | |||
| P1433 | published in | International Journal of Molecular Sciences | Q3153277 |
| P1476 | title | Selenium Species: Current Status and Potentials in Cancer Prevention and Therapy | |
| P478 | volume | 20 |
| Q92632900 | Novel N,N'-Disubstituted Acylselenoureas as Potential Antioxidant and Cytotoxic Agents |
| Q92811033 | Selenium Anticancer Properties and Impact on Cellular Redox Status |
| Q98770554 | Selenium Protects against Zearalenone-Induced Oxidative Stress and Apoptosis in the Mouse Kidney by Inhibiting Endoplasmic Reticulum Stress |
| Q93108251 | Selenium and Health: An Update on the Situation in the Middle East and North Africa |
| Q92286619 | Sodium Selenite Enhanced the Anti-proliferative Effect of MEK-ERK Inhibitor in Thyroid Cancer Cells |
| Q92705169 | The Application of Pollen as a Functional Food and Feed Ingredient-The Present and Perspectives |
| Q92592218 | Understanding of ROS-Inducing Strategy in Anticancer Therapy |
Search more.